23 Feb Regenerative Patch Technologies
Jane Lebkowski, Ph.D., President
Menlo Park, CA
Regenerative Patch Technologies (RPT) is a clinical-stage company developing a stem cell-based implant technology for the treatment of retinal diseases. The CPCB-RPE1 implant, RPT’s lead product, is a bio-engineered implant consisting of stem cell-derived, mature, polarized retinal pigmented epithelial cells on an ultrathin synthetic parylene membrane. The implant is designed to replace the retinal pigmented epithelium and Bruch’s membrane which are critical functional elements of the eye that degenerate in dry age-related macular degeneration.